Wolf Douglas C, Naegeli April N, Moore Page C, Janak Jud C, Crabtree Margaux M, Shan Mingyang, Hunter Theresa M, Sontag Angelina, Cross Raymond K
Atlanta Gastroenterology Associates, Atlanta, Georgia.
Eli Lilly and Company, Indianapolis, Indiana.
Gastro Hep Adv. 2023 Apr 6;2(6):799-809. doi: 10.1016/j.gastha.2023.03.024. eCollection 2023.
Fecal urgency is a common symptom of Ulcerative Colitis (UC). We explored the association between changes in fecal urgency for patient characteristics and evaluated the association between change in treatment and change in fecal urgency.
The study cohort (n = 400) included UC patients in the CorEvitas Inflammatory Bowel Disease Registry between May 3, 2017 and September 1, 2020. Fecal urgency was defined using the Simple Clinical Colitis Activity Index. Urgency groups were formed by urgency at enrollment and 6-month follow-up visit: no persistent urgency at both visits (NPU); change from urgency to no urgency (UN); change from no urgency to urgency (NU); and persistent urgency at both visits (PU). Descriptive statistics were used to explore between urgency group differences at baseline and Kaplan-Meier curves to compare time to first treatment change.
Groups included NPU (n = 175), UN (n = 86), NU (n = 56), and PU (n = 83). At enrollment, we found differences between groups for increased depression, anxiety, prior infections, diabetes; also, greater fatigue, pain, work impairment, work hours affected, and daily activities impacted. Compared to NPU patients, UN, NU, and PU patients were more likely to change treatment between enrollment and 6-month follow-up visit, and a higher proportion of UN, NU, and PU patients on a biologic at enrollment changed treatment vs the NPU group between both visits.
Among real-world UC patients, fecal urgency status is associated with increased comorbidities and worse patient-reported outcomes and significant differences in change of treatment and time to treatment change. Urgency at any time point diminishes quality of life and may be a sign of inadequate therapy, which often is an indication to switch therapy.
排便急迫是溃疡性结肠炎(UC)的常见症状。我们探讨了排便急迫变化与患者特征之间的关联,并评估了治疗变化与排便急迫变化之间的关联。
研究队列(n = 400)包括2017年5月3日至2020年9月1日期间CorEvitas炎症性肠病登记处的UC患者。排便急迫采用简单临床结肠炎活动指数进行定义。根据入组时和6个月随访时的急迫情况形成急迫组:两次就诊时均无持续急迫(NPU);从急迫变为无急迫(UN);从无急迫变为急迫(NU);两次就诊时均持续急迫(PU)。采用描述性统计来探讨基线时急迫组之间的差异,并使用Kaplan-Meier曲线比较首次治疗改变的时间。
分组包括NPU(n = 175)、UN(n = 86)、NU(n = 56)和PU(n = 83)。在入组时,我们发现各组之间在抑郁增加、焦虑、既往感染、糖尿病方面存在差异;此外,疲劳、疼痛、工作受损、工作时间受影响以及日常活动受影响程度也更大。与NPU患者相比,UN、NU和PU患者在入组至6个月随访期间更有可能改变治疗,且入组时使用生物制剂的UN、NU和PU患者在两次就诊之间改变治疗的比例高于NPU组。
在真实世界的UC患者中,排便急迫状态与合并症增加、患者报告的结局较差以及治疗改变和治疗改变时间的显著差异相关。任何时间点的急迫都会降低生活质量,可能是治疗不足的迹象,这通常是更换治疗的指征。